These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33876948)

  • 1. Catalytically Enhanced Cas9 through Directed Protein Evolution.
    Hand TH; Roth MO; Smith CL; Shiel E; Klein KN; Gilbert DM; Li H
    CRISPR J; 2021 Apr; 4(2):223-232. PubMed ID: 33876948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the Genome-Editing Toolbox with
    Nakamura A; Yamamoto H; Yano T; Hasegawa R; Makino Y; Mitsuda N; Terakawa T; Ito S; Sugano SS
    CRISPR J; 2024 Aug; 7(4):197-209. PubMed ID: 39111827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis for recognition of 5'-NNNCC-3' PAM and its methylation state by Acidothermus cellulolyticus Cas9.
    Das A; Hand TH; Smith CL; Wickline E; Zawrotny M; Li H
    Nat Commun; 2020 Dec; 11(1):6346. PubMed ID: 33311465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides.
    Ding X; Seebeck T; Feng Y; Jiang Y; Davis GD; Chen F
    CRISPR J; 2019 Feb; 2():51-63. PubMed ID: 31021236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.
    Jain S; Xun G; Abesteh S; Ho S; Lingamaneni M; Martin TA; Tasan I; Yang C; Zhao H
    ACS Synth Biol; 2021 Jun; 10(6):1320-1327. PubMed ID: 34006094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
    Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
    Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
    Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
    Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
    Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
    Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
    Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
    Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA.
    Liu MS; Gong S; Yu HH; Jung K; Johnson KA; Taylor DW
    Nat Commun; 2020 Jul; 11(1):3576. PubMed ID: 32681021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directed evolution studies of a thermophilic Type II-C Cas9.
    Hand TH; Das A; Li H
    Methods Enzymol; 2019; 616():265-288. PubMed ID: 30691646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Inhibitors of CRISPR-Cas9.
    Bondy-Denomy J
    ACS Chem Biol; 2018 Feb; 13(2):417-423. PubMed ID: 29251498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed Evolution of CRISPR-Cas9 Base Editors.
    Winter J; Perez-Pinera P
    Trends Biotechnol; 2019 Nov; 37(11):1151-1153. PubMed ID: 31623959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New variants of CRISPR RNA-guided genome editing enzymes.
    Murovec J; Pirc Ž; Yang B
    Plant Biotechnol J; 2017 Aug; 15(8):917-926. PubMed ID: 28371222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphate Lock Residues of Acidothermus cellulolyticus Cas9 Are Critical to Its Substrate Specificity.
    Hand TH; Das A; Roth MO; Smith CL; Jean-Baptiste UL; Li H
    ACS Synth Biol; 2018 Dec; 7(12):2908-2917. PubMed ID: 30458109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing using Cas9 nickases.
    Trevino AE; Zhang F
    Methods Enzymol; 2014; 546():161-74. PubMed ID: 25398340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogold Labeling to Detect
    Ulloa-Navas MJ; García-Tárraga P; García-Verdugo JM; Herranz-Pérez V
    CRISPR J; 2019 Dec; 2(6):395-405. PubMed ID: 31860352
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Yourik P; Fuchs RT; Mabuchi M; Curcuru JL; Robb GB
    RNA; 2019 Jan; 25(1):35-44. PubMed ID: 30348755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9.
    Maji B; Gangopadhyay SA; Lee M; Shi M; Wu P; Heler R; Mok B; Lim D; Siriwardena SU; Paul B; Dančík V; Vetere A; Mesleh MF; Marraffini LA; Liu DR; Clemons PA; Wagner BK; Choudhary A
    Cell; 2019 May; 177(4):1067-1079.e19. PubMed ID: 31051099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.